• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma

byTeddy Guo
August 26, 2021
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click to read the study in The Lancet Oncology. 

RELATED REPORTS

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

Tags: camrelizumabCisplatinEpstein-Barr virus (EBV)gemcitabinehead and neck cancernasopharyngealnasopharyngeal cancernasopharyngeal carcinomaplasma EBV (pEBV)plasma EBV DNA
Previous Post

Wellness Check: Exercise

Next Post

#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

RelatedReports

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025
#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma
StudyGraphics

#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma

March 26, 2025
#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma
StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025
Adaptive interim PET-CT guides treatment for advanced Hodgkin’s lymphoma
Oncology

High incidence of post-transplant lymphoproliferative disorder in Epstein-Barr virus-seronegative kidney recipients

January 27, 2025
Next Post
#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

Pediatric renal and thyroid cancer rates increase

Multifocal papillary thyroid carcinoma has a higher risk of recurrence than unifocal cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • One in Six Medicare Beneficiaries Use Telehealth for Essential Care
  • Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia
  • Deep-learning models displayed expert-level accuracy in detecting epileptiform discharges on electroencephalogram (EEG) recordings
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.